AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nimcare 50mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Alde Medi Impex Ltd

Salt Composition

Nimesulide (50mg)

Overview Nimcare 50mg Tablet DT

Infants and children experiencing acute pain or fever may be treated with the NSAID, PediCare 50mg Tablet DT. This medication effectively reduces pain and fever. Administer the prescribed dosage at the specified intervals, preferably after meals to minimize stomach upset. Though it can be given before or after food, post-meal administration is recommended. Never exceed the recommended dose; doing so may lead to adverse reactions. If vomiting occurs within 30 minutes of administration, repeat the dose; however, omit if it's nearing the next scheduled dose. Potential side effects include nausea, vomiting, abdominal pain, heartburn, diarrhea, and allergic reactions. These are typically transient and resolve as the child adjusts to the medication. Persistent or bothersome side effects necessitate immediate consultation with a pediatrician. Before administering PediCare 50mg Tablet DT, disclose any existing allergies, heart conditions, congenital anomalies, liver, kidney, lung disorders, or bleeding problems. This is essential for proper dosage adjustment and treatment planning. **Important:** PediCare 50mg Tablet DT is contraindicated for children under 12 years of age (as per Ministry of Health and Family Welfare guidelines).

Uses of Nimcare 50mg Tablet DT

Fever and pain management

Major Benefits of Nimcare 50mg Tablet DT:

Consume this medication according to your physician's prescribed dosage and schedule. Dissolve the tablet in water before ingestion. Ingest Nimcare 50mg Tablet DT with a meal.

Common Side effects of Nimcare 50mg Tablet DT:

  • Stomach pain
  • Nausea
  • Allergy
  • Diarrhea
  • Vomiting
  • Increased liver enzymes

How to use Nimcare 50mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Nimcare 50mg Tablet DT in water before consumption. Administer this medicine with a meal.

How Nimcare 50mg Tablet DT works:

Nimcare 50mg Delayed-Release Tablets inhibit prostaglandins, thereby alleviating pain, fever, and inflammatory responses like redness and swelling.

SAFETY ADVICE

KidneyKidneyCAUTION

Patients with kidney impairment should use Nimcare 50mg Tablet DT cautiously, potentially requiring dosage modification. Consult a physician. Nimcare 50mg Tablet DT is contraindicated in those with severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Nimcare 50mg Tablet DT. Dosage modification of Nimcare 50mg Tablet DT might be necessary; physician consultation is advised. Routine Liver Function Tests (LFTs) are recommended for children during Nimcare 50mg Tablet DT treatment.

What if you forget to take Nimcare 50mg Tablet DT :

Remain calm. Unless otherwise directed by your pediatrician, a missed dose can be administered if less than twelve hours have elapsed. However, if the next dose is imminent, avoid doubling the medication and instead adhere to the recommended dosing instructions.

Facts to Know About Nimcare 50mg Tablet DT

LabelValue
Type of Compound Diphenyl ether-based compound
Potential for Dependence None.
Medication Classification Medications for Pain Relief

FAQs on Nimcare 50mg Tablet DT

Adjusting your child's medication dosage independently is strongly discouraged. Increasing the dose without medical supervision risks harmful side effects, while reducing it could allow symptoms to return. To ensure optimal treatment, discuss any potential dosage changes with your pediatrician.
The dosage your physician determines will be tailored to your child's health status and weight. Adhering precisely to this prescribed regimen is crucial for your child's safe and full recovery.
Extended use of Nimcare 50mg Delayed-Release Tablets may raise stomach acid production. Elevated acid levels can cause ulcers, potentially resulting in gastrointestinal hemorrhage. Consequently, the minimal effective dose should be used for the briefest necessary period. Seek medical advice if uncertain.
Store Nimcare 50mg Delayed-Release Tablets at room temperature, in a dry location, shielded from direct sunlight and heat. Keep the medication out of children's reach and view to prevent unintentional ingestion.
Nimcare 50mg Tablet DT dosage isn't standardized across all patients. A physician determines the correct dose for each child, considering their age and weight.
Administering Nimcare 50mg Tablet DT to your child might be necessary for a short to extended period, contingent on the infection's intensity. Should symptoms persist following the complete prescribed dosage, promptly seek your pediatrician's advice.
While Nimcare 50mg DT tablets are generally safe for children, seek immediate medical attention if your child develops any severe adverse effects such as persistent vomiting, edema, liver damage, reduced urination, or a serious allergic response.
Nimcare 50mg Delayed-Release Tablets are not antibiotics; rather, they're classified as non-steroidal anti-inflammatory drugs (NSAIDs), providing pain relief for a range of medical conditions.
Diclofenac 50mg extended-release tablets and acetaminophen are both categorized as non-steroidal anti-inflammatory drugs (NSAIDs), a group of medications that alleviate pain. Concurrent use of these two drugs is discouraged due to a heightened risk of stomach ulcers and hemorrhage. Physician consultation is recommended prior to combined administration.
Nimcare 50mg Delayed-Release Tablets are a non-steroidal anti-inflammatory medication, providing analgesic relief. This formulation is aspirin-free.
Taking Nimcare 50mg DT tablets as directed by a physician, within the recommended dosage and timeframe, is considered safe.
Use of Nimcare 50mg Delayed-Release Tablets for headache relief should only occur under physician supervision.
Nimcare 50mg DT tablets, when taken as directed, do not cause drowsiness. Excessive consumption of Nimcare 50mg DT tablets, however, may induce drowsiness.
Nimcare 50mg Tablet DT is free of sulfur.
Nimcare 50mg Delayed-Release Tablets are indicated for the management of acute pain, the discomfort associated with osteoarthritis, and primary dysmenorrhea in patients aged 12 years and older.
Nimcare 50mg Delayed-Release Tablets may be used concurrently with ibuprofen; no documented interactions exist. Despite this, combined use is discouraged due to a heightened risk of gastrointestinal ulceration and hemorrhage. Physician consultation is recommended prior to concomitant administration.
Concurrent use of Nimcare 50mg DT tablets and aspirin has shown no clinically documented adverse interactions. Nevertheless, the possibility of unforeseen interactions remains. Physician consultation is advised prior to combining these medications.
Taking Nimcare 50mg Delayed-Release Tablets as directed by your physician, within the recommended timeframe and dosage, is considered safe.
Nimcare 50mg Tablet DT remains available for sale in India.
The presence of Nimcare 50mg Tablet DT in breast milk is undetermined. Therefore, medications incorporating Nimcare 50mg Tablet DT should be avoided while breastfeeding.
Using Nimcare 50mg Tablet DT during pregnancy, particularly in the final trimester, is not advisable. Reports link maternal Nimcare 50mg Tablet DT use late in pregnancy to neonatal kidney problems. Pregnant individuals should always seek medical counsel before using any medication.
Patients with asthma can generally use Nimcare 50mg DT tablets safely when administered according to their physician's instructions. Nevertheless, individuals with asthma should always disclose their medical history, including any concurrent medications, to their doctor before starting Nimcare.
Nimcare 50mg Delayed-Release Tablets are not antibiotics; they are non-steroidal anti-inflammatory drugs (NSAIDs) that alleviate pain stemming from diverse medical conditions.
Nimcare 50mg DT tablets and paracetamol are both classified as non-steroidal anti-inflammatory drugs (NSAIDs), a type of analgesic. Concurrent use of these medications is discouraged due to the heightened risk of stomach ulcers and bleeding. A physician's consultation is recommended prior to combining these two drugs.
Nimcare 50mg Delayed-Release Tablets are a non-steroidal anti-inflammatory medication, providing pain relief. This formulation is aspirin-free.
Using Nimcare 50mg DT tablets as directed by a physician is considered safe.
Use of the medication Nimcare 50mg DT tablets for headache relief should only occur under explicit physician instruction.
Nimcare 50mg Tablet DT, at recommended dosages, does not induce drowsiness. Nevertheless, exceeding the prescribed dose of Nimcare 50mg Tablet DT may cause drowsiness.
Nimcare 50mg Tablet DT is free of sulfur.
Nimcare 50mg extended-release tablets are indicated for the management of acute pain, the discomfort associated with osteoarthritis, and primary dysmenorrhea in patients aged 12 and older.
While Nimcare 50mg DT tablets may be used concurrently with ibuprofen, reported drug interactions are absent. Nevertheless, combined use isn't recommended due to a heightened risk of stomach ulcers and bleeding. Always seek medical advice prior to concurrent administration.
Concurrent use of Nimcare 50mg Delayed-Release tablets and aspirin has not shown clinically significant interactions. Nevertheless, the possibility of unforeseen interactions remains. Physician consultation is advised prior to combined administration.
The medication Nimcare 50mg Tablet DT remains available in India. Nevertheless, the Indian Ministry of Health and Family Welfare prohibits its use in children younger than twelve.
The presence of Nimcare 50mg Tablet DT in breast milk is undetermined. Therefore, medications incorporating Nimcare 50mg Tablet DT should be avoided while breastfeeding.
Using Nimcare 50mg Tablet DT during pregnancy, particularly in the final trimester, is inadvisable due to documented cases of neonatal kidney failure in infants whose mothers used this medication late in their pregnancies. Pregnant individuals should always seek medical advice before using any medication.
Patients with asthma can generally use Nimcare 50mg DT tablets safely, provided they follow their physician's instructions. Nevertheless, individuals with asthma should always disclose their condition and any other medications they are taking to their doctor before starting Nimcare.
Nimcare 50mg Tablet DT
16
MRP 20
19% off